Liraglutide improves nonalcoholic fatty liver disease by regulation of sestrin2-mediated activation of AMPK/Nrf2/HO-1 pathway in obese miceX. Han,F. Han, R. Pan,N. Hou,Y. Liu,X. SunDIABETOLOGIA(2019)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要